Olema Oncology to Participate in Upcoming Investor Conferences
06 Februar 2024 - 1:01PM
Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq:
OLMA), a biopharmaceutical company focused on the discovery,
development, and commercialization of targeted therapies for
women’s cancers, today announced that the Company will participate
in the following upcoming investor conferences:
- Sean P. Bohen, M.D., Ph.D.,
President and Chief Executive Officer, will participate in a
virtual Fireside Chat at the Oppenheimer
34th Annual Healthcare Life
Sciences Conference on Tuesday, February 13, 2024, at
10:40 a.m. ET.
- Shane Kovacs, Chief Operating
Officer, will participate in a panel discussion on Breast &
Lung Cancer at TD Cowen’s 44th
Annual Health Care Conference at the Marriott
Copley Place in Boston, MA, on Wednesday, March 6, 2024, at 9:10
a.m. ET.
- Olema management will attend the
Jefferies Biotech on the Bay Summit in Miami, FL,
on Tuesday, March 12, 2024.
A live webcast of the Fireside Chat and panel and any
accompanying presentation materials will be available under the
News & Events section of Olema’s investor relations website at
ir.olema.com. The webcasts will be archived for at least 30
days.
About Olema OncologyOlema Oncology is a
biopharmaceutical company committed to transforming the standard of
care and improving outcomes for women living with cancer. Olema is
advancing a pipeline of novel therapies by leveraging our deep
understanding of endocrine-driven cancers, nuclear receptors, and
mechanisms of acquired resistance. In addition to our lead product
candidate, palazestrant (OP-1250), a proprietary, orally-available
complete estrogen receptor (ER) antagonist (CERAN) and a selective
ER degrader (SERD), Olema is developing a potent KAT6 inhibitor
(OP-3136). Olema is headquartered in San Francisco and has
operations in Cambridge, Massachusetts. For more information,
please visit us at www.olema.com.
Contact:Geoffrey Mogilner, Vice President, Investor Relations
and Communicationsir@olema.com
Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024